Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

about

Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

Item

http://www.wikidata.org/entity/Q47652466

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@en

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@nl

type

Item

label

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@en

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@nl

prefLabel

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@en

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@nl

P1476

Peak Inspiratory Flow Rate in ...... tions for Dry Powder Inhalers.

@en

P2093

Jill A Ohar

http://www.w3.org/2001/XMLSchema#string

M Bradley Drummond

http://www.w3.org/2001/XMLSchema#string

Sohini Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice

Inhalation device requirements for patients' inhalation maneuvers

Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.

Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.

The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.

What the pulmonary specialist should know about the new inhalation therapies.

The role of nebulized therapy in the management of COPD: evidence and recommendations.

P304

381-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JAMP.2017.1416

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28933581

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5915227

http://www.w3.org/2001/XMLSchema#string